STEM CELL THERAPY IN END STAGE LIVER DISEASE AND LIVER FAILURE

Debashis Chowdhury
{"title":"STEM CELL THERAPY IN END STAGE LIVER DISEASE AND LIVER FAILURE","authors":"Debashis Chowdhury","doi":"10.4066/2249-622x-c5-015","DOIUrl":null,"url":null,"abstract":"Liver cells have a tremendous capacity to multiply and regenerate the liver after any injury. However, this regenerative capacity of liver cells may be overwhelmed in acute liver failure and exhausted in cirrhosis with end stage liver disease. Currently liver transplantation is the only definitive treatment for these conditions of liver. However, due to the shortage of donor organs many patients are dying while on waitlist for liver transplantation. As a result it has become important to find an alternative strategy to keep these patients alive until their own livers regenerate or donor organs become available. Regenerative medicine and stem cell transplantation can help these patients. Adult stem cells and induced pluripotent stem cells showed good results when transplanted in experimental animals. Stem cells engineered from patients’ own tissue proved to be safe, as well as non-immunogenic in clinical trials. Present review will discuss the current state of stem cell therapy, available stem cells and their application in different liver diseases.","PeriodicalId":8517,"journal":{"name":"Asian Journal of Biomedical and Pharmaceutical Sciences","volume":"53 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Asian Journal of Biomedical and Pharmaceutical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4066/2249-622x-c5-015","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Liver cells have a tremendous capacity to multiply and regenerate the liver after any injury. However, this regenerative capacity of liver cells may be overwhelmed in acute liver failure and exhausted in cirrhosis with end stage liver disease. Currently liver transplantation is the only definitive treatment for these conditions of liver. However, due to the shortage of donor organs many patients are dying while on waitlist for liver transplantation. As a result it has become important to find an alternative strategy to keep these patients alive until their own livers regenerate or donor organs become available. Regenerative medicine and stem cell transplantation can help these patients. Adult stem cells and induced pluripotent stem cells showed good results when transplanted in experimental animals. Stem cells engineered from patients’ own tissue proved to be safe, as well as non-immunogenic in clinical trials. Present review will discuss the current state of stem cell therapy, available stem cells and their application in different liver diseases.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
终末期肝病和肝衰竭的干细胞治疗
肝细胞在任何损伤后都有巨大的繁殖和再生能力。然而,肝细胞的这种再生能力可能在急性肝功能衰竭时被淹没,在肝硬化伴终末期肝病时耗尽。目前,肝移植是治疗这些肝脏疾病的唯一确定方法。然而,由于供体器官的短缺,许多患者在等待肝移植的过程中死亡。因此,找到一种替代策略来维持这些患者的生命,直到他们自己的肝脏再生或供体器官可用,就变得非常重要。再生医学和干细胞移植可以帮助这些患者。成体干细胞和诱导多能干细胞在实验动物身上的移植均取得了良好的效果。从患者自身组织中提取的干细胞在临床试验中被证明是安全的,而且没有免疫原性。本文将讨论干细胞治疗的现状、可用的干细胞及其在不同肝脏疾病中的应用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Extemporaneous preparation as the last resort for drug shortage during covid-19 pandemic-lessons learned A unique combination of Alchornea cordifolia and Pterocarpus santalinoides in the management of multi-drug resistant diarrhoegenic bacterial infection. A review on: Soil microbes effect on human health. Could covid-19 virus be airborne? Pros and Challenges to Pharmacists in Prescribing Practice.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1